Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 12,615 | 11,360 | 8,942 | 8,426 | 5,786 |
| Cost of Goods | 7,259 | 6,572 | 5,181 | 5,557 | 4,445 |
| Gross Profit | 5,356 | 4,788 | 3,761 | 2,869 | 1,341 |
| Operating Expenses | 21,573 | 21,152 | 20,520 | 18,089 | 14,898 |
| Operating Income | -15,958 | -15,792 | -16,578 | -14,663 | -13,112 |
| Interest Expense | 1,299 | 1,136 | 1,060 | 1,079 | 1,079 |
| Other Income | 439 | 196 | 46 | 11 | 1,514 |
| Pre-tax Income | -16,818 | -16,732 | -17,592 | -15,731 | -12,677 |
| Income Tax | N/A | N/A | 4 | 2 | -4 |
| Net Income Continuous | -16,818 | -16,732 | -17,596 | -15,733 | -12,673 |
| Net Income | $-16,818 | $-16,732 | $-17,596 | $-15,733 | $-12,673 |
| EPS Basic Total Ops | -0.61 | -0.61 | -0.64 | 2.09 | -0.68 |
| EPS Basic Continuous Ops | -0.61 | -0.61 | -0.64 | 2.09 | -0.68 |
| EPS Diluted Total Ops | -0.61 | -0.61 | -0.64 | 2.34 | -0.68 |
| EPS Diluted Continuous Ops | -0.61 | -0.61 | -0.64 | 2.04 | -0.68 |
| EBITDA(a) | $-15,226 | $-14,795 | $-15,460 | $-13,523 | $-11,974 |